Orchid Asia Group Management
Hong Kong SARorchidasia.com
Overview
Orchid Asia Group Management is an investment group with offices in Hong Kong, Shanghai, Beijing, and Guangzhou. The firm focuses on backing experienced executives in building franchises in Asia, with an emphasis in China. They seek to invest in expanding domestic enterprises in high barrier to entry businesses that have good growth prospects in the consumer services and products sector, as well as the outsourced manufacturing and services sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Raise Financial | Oct 2025 | Series B | Co-investor |
| Shenzhen Andun Intellectual Property Service Co., Ltd. | Sep 2021 | Series B | Lead |
| Shenzhen Jishi Collaboration Technology Co., Ltd. | Sep 2021 | Series C Extension | Co-investor |
| Abogen Biosciences | Aug 2021 | Series C | - |
| JOVS | Jul 2021 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
